Table 2.

Contrasts between control and BAV cohorts at each analysis location.

	Location
	LVOT			SOV			MAA			AA1
Parameter	Control	BAV	P	Control	BAV	P	Control	BAV	P	Control	BAV	P
Indexed diameter (mm/m2)	13.23 ± 1.73	14.44 ± 2.00	<.01	14.21 ± 2.32	19.40 ± 3.60	<.01	14.81 ± 2.17	19.04 ± 4.05	<.01	13.86 ± 2.18	15.62 ± 3.63	.02
Net flow (mL)	79.41 ± 19.10	84.28 ± 19.58	.3	87.00 ± 20.96	77.98 ± 19.67	.05	74.50 ± 19.36	62.61 ± 22.00	.02	72.85 ± 18.06	64.29 ± 2130	.06
Regurgitation (%)	2.04 ± 2.22	9.02 ± 11.25	<.01	1.42 ± 1.72	12.58 ± 13.94	<.01	2.67 ± 3.19	19.90 ± 21.13	<.01	2.61 ± 4.21	18.28 ± 17.61	<.01
Peak velocity (m/s)	1.16 ± 0.18	1.10 ± 0.22	.6	1.44 ± 0.16	2.05 ± 0.65	<.01	1.13 ± 0.25	1.55 ± 0.53	<.01	0.98 ± 0.25	1.24 ± 0.38	<.01
WSSM,avg (Pa)	0.17 ± 0.06	0.12 ± 0.06	<.01	0.18 ± 0.07	0.12 ± 0.07	<.01	0.19 ± 0.07	0.15 ± 0.07	.2	0.22 ± 0.07	0.20 ± 0.08	.2
WSSM,max (Pa)	0.73 ± 0.18	0.74 ± 0.21	.8	0.84 ± 0.26	0.93 ± 0.27	.2	0.76 ± 0.24	1.00 ± 0.29	.04	0.73 ± 0.20	0.88 ± 0.29	.1
WSSA,avg (Pa)	0.48 ± 0.13	0.45 ± 0.13	.3	0.36 ± 0.17	0.23 ± 0.13	<.01	0.37 ± 0.12	0.37 ± 0.13	1.0	0.43 ± 0.10	0.45 ± 0.14	.5
WSSA,max (Pa)	0.65 ± 0.15	0.60 ± 0.17	.4	0.66 ± 0.21	0.67 ± 0.23	.9	0.56 ± 0.18	0.71 ± 0.25	.01	0.62 ± 0.24	0.65 ± 0.22	.6
WSSC,avg (Pa)	0.10 ± 0.03	0.12 ± 0.04	<.01	0.10 ± 0.02	0.13 ± 0.05	<.01	0.15 ± 0.06	0.27 ± 0.11	<.01	0.11 ± 0.06	0.24 ± 0.14	<.01
WSSC,max (Pa)	0.25 ± 0.14	0.27 ± 0.12	.6	0.31 ± 0.13	0.38 ± 0.17	.2	0.32 ± 0.12	0.46 ± 0.21	<.01	0.27 ± 0.11	0.35 ± 0.18	.2
PDsys (mm Hg)	–	–	–	1.16 ± 1.43	5.42 ± 4.47	<.01	2.80 ± 2.37	9.48 ± 7.95	<.01	3.23 ± 2.59	8.39 ± 9.23	<.01

LVOT, left ventricular outflow tract; MAA, mid-ascending aorta; PD, pressure drop.